| [1] |
Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016 [J]. Journal of the National Cancer Center, 2022, 2(1): 1-9.
|
| [2] |
Chang HY, Chi JT, Dudoit S, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts [J]. Proc Natl Acad Sci USA, 2002, 99(20): 12877-12882.
|
| [3] |
Mueller L, Goumas FA, Affeldt M, et al. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment [J]. Am J Pathol, 2007, 171(5): 1608-1618.
|
| [4] |
Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis [J]. Nature, 2007, 449(7162): 557-563.
|
| [5] |
Iwano M, Plieth D, Danoff T M, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis [J]. Journal of Clinical Investigation, 2002, 110(3): 341-350.
|
| [6] |
Zeisberg EM, Potenta S, Xie L, et al. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts [J]. Cancer Res, 2007, 67(21): 10123-10128.
|
| [7] |
Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion [J]. Cancer Res, 2011, 71(7): 2455-2465.
|
| [8] |
Bochet L, Lehuede C, Dauvillier S, et al. Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer[J]. Cancer Res, 2013, 73(18): 5657-5668.
|
| [9] |
Hosaka K, Yang Y, Seki T, et al. Pericyte-fibroblast transition promotes tumor growth and metastasis [J]. Proc Natl Acad Sci USA, 2016, 113(38): E5618-5627.
|
| [10] |
Omary MB, Lugea A, Lowe AW, et al. The pancreatic stellate cell: a star on the rise in pancreatic diseases [J]. J Clin Invest, 2007, 117(1): 50-59.
|
| [11] |
Masamune A, Kikuta K, Watanabe T, et al. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells [J]. Gut, 2009, 58(4): 550-559.
|
| [12] |
Kobayashi H, Gieniec KA, Lannagan TRM, et al. The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis [J]. Gastroenterology, 2022, 162(3): 890-906.
|
| [13] |
Calon A, Espinet E, Palomo-Ponce S, et al. Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation[J]. Cancer Cell, 2012, 22(5): 571-584.
|
| [14] |
Steele NG, Biffi G, Kemp SB, et al. Inhibition of hedgehog signaling alters fibroblast composition in pancreatic cancer[J]. Clin Cancer Res, 2021, 27(7): 2023-2037.
|
| [15] |
Heichler C, Scheibe K, Schmied A, et al. STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis [J]. Gut, 2020, 69(7): 1269-1282.
|
| [16] |
Xi L, Peng M, Liu S, et al. Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion [J]. J Extracell Vesicles, 2021, 10(11): e12146.
|
| [17] |
Li Z, Zhang J, Zhou J, et al. Nodal facilitates differentiation of fibroblasts to cancer-associated fibroblasts that support tumor growth in melanoma and colorectal cancer [J]. Cells, 2019, 8(6): 538.
|
| [18] |
Franzè E, Di Grazia A, Sica GS, et al. Interleukin-34 enhances the tumor promoting function of colorectal cancer-associated fibroblasts[J]. Cancers (Basel), 2020, 12(12): 3537.
|
| [19] |
Ozdemir BC, Pentcheva-Hoang T, Carstens JL, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival [J]. Cancer Cell, 2014, 25(6): 719-734.
|
| [20] |
Kobayashi H, Enomoto A, Woods SL, et al. Cancer-associated fibroblasts in gastrointestinal cancer [J]. Nature Reviews Gastroenterology & Hepatology, 2019, 16(5): 282-295.
|
| [21] |
Li H, Courtois ET, Sengupta D, et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors [J]. Nat Genet, 2017, 49(5): 708-718.
|
| [22] |
Yang M, Wei Z, Feng M, et al. Pharmacological inhibition and genetic knockdown of BCL9 modulate the cellular landscape of cancer-associated fibroblasts in the tumor-immune microenvironment of colorectal cancer[J]. Front Oncol, 2021, 11: 603556.
|
| [23] |
Nishina T, Deguchi Y, Ohshima D, et al. Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer [J]. Nat Commun, 2021, 12(1): 2281.
|
| [24] |
Valenciano A, Henriquez-Hernandez LA, Moreno M, et al. Role of IGF-1 receptor in radiation response [J]. Transl Oncol, 2012, 5(1): 1-9.
|
| [25] |
Zhou W, Xu G, Wang Y, et al. Oxidative stress induced autophagy in cancer associated fibroblast enhances proliferation and metabolism of colorectal cancer cells [J]. Cell Cycle, 2017, 16(1): 73-81.
|
| [26] |
Castellana D, Zobairi F, Martinez MC, et al. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis [J]. Cancer Res, 2009, 69(3): 785-793.
|
| [27] |
Bhome R, Goh RW, Bullock MD, et al. Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression [J]. Aging-Us, 2017, 9(12): 2666-2694.
|
| [28] |
Zheng Y, Zeng J, Lin D, et al. Extracellular vesicles derived from cancer-associated fibroblast carries miR-224-5p targeting SLC4A4 to promote the proliferation, invasion and migration of colorectal cancer cells [J]. Carcinogenesis, 2021, 42(9): 1143-1153.
|
| [29] |
Zhou L, Li J, Tang Y, et al. Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis [J]. J Transl Med, 2021, 19(1): 8.
|
| [30] |
Hu JL, Wang W, Lan X L, et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer [J]. Mol Cancer, 2019, 18(1): 91.
|
| [31] |
Mosa MH, Michels BE, Menche C, et al. A wnt-induced phenotypic switch in cancer-associated fibroblasts inhibits EMT in colorectal cancer [J]. Cancer Res, 2020, 80(24): 5569-5582.
|
| [32] |
Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies [J]. Semin Cancer Biol, 2020, 65(1): 76-88.
|
| [33] |
Zhang C, Wang XY, Zhang P, et al. Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts [J]. Cell Death Dis, 2022, 13(1): 57.
|
| [34] |
Boardman LA. Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer [J]. Genome Med, 2009, 1(4): 36.
|
| [35] |
Luraghi P, Reato G, Cipriano E, et al. MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors [J]. Cancer Res, 2014, 74(6): 1857-1869.
|
| [36] |
Tommelein J, De Vlieghere E, Verset L, et al. Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation [J]. Cancer Research, 2018, 78(3): 659-670.
|
| [37] |
Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer [J]. Cancer Cell, 2009, 15(2): 103-113.
|
| [38] |
Gong J, Lin Y, Zhang H, et al. Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells [J]. Cell Death Dis, 2020, 11(4): 267.
|
| [39] |
Nagasaki T, Hara M, Nakanishi H, et al. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction [J]. Br J Cancer, 2014, 110(2): 469-478.
|
| [40] |
Dai X, Xie Y, Dong M. Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p/FOXO1 axis [J]. Cancer Biology & Therapy, 2022, 23(1): 76-88.
|
| [41] |
Unterleuthner D, Neuhold P, Schwarz K, et al. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer [J]. Angiogenesis, 2020, 23(2): 159-177.
|
| [42] |
Zhang R, Qi F, Zhao F, et al. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer [J]. Cell Death Dis, 2019, 10(4): 273.
|
| [43] |
Li T, Yi S, Liu W, et al. Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity [J]. Med Oncol, 2013, 30(3): 663.
|
| [44] |
Huang TX, Tan XY, Huang HS, et al. Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity [J]. Gut, 2022, 71(2): 333-344.
|
| [45] |
Harryvan TJ, Visser M, de Bruin L, et al. Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S [J]. J Immunother Cancer, 2022, 10(3): e003591.
|
| [46] |
Lakins MA, Ghorani E, Munir H, et al. Cancer-associated fibroblasts induce antigen-specific deletion of CD8(+) T Cells to protect tumour cells [J]. Nature Communications, 2018, 9(1): 948.
|
| [47] |
Gao Y, Sun Z, Gu J, et al. Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer [J]. Front Oncol, 2021, 11748465.
|
| [48] |
Li Z, Zhou J, Zhang J, et al. Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5 [J]. Int J Cancer, 2019, 145(7): 1946-1957.
|
| [49] |
Jacobs J, Deschoolmeester V, Zwaenepoel K, et al. Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation [J]. Oncoimmunology, 2018, 7(7): e1440167.
|
| [50] |
Clarke SL, Betts GJ, Plant A, et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer [J]. Plos One, 2006, 1(1): e129.
|
| [51] |
Kumar V, Donthireddy L, Marvel D, et al. Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors [J]. Cancer Cell, 2017, 32(5): 654-668, e5.
|
| [52] |
Calvo F, Ege N, Grande-Garcia A, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts [J]. Nat Cell Biol, 2013, 15(6): 637-646.
|
| [53] |
Bauer J, Emon MAB, Staudacher JJ, et al. Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling [J]. Sci Rep-Uk, 2020, 10(1): 50.
|
| [54] |
Cho C, Mukherjee R, Peck AR, et al. Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesis [J]. Oncogene, 2020, 39(38): 6129-6137.
|
| [55] |
Khawar IA, Kim JH, Kuh HJ. Improving drug delivery to solid tumors: priming the tumor microenvironment [J]. J Control Release, 2015, 201: 78-89.
|
| [56] |
Ren J, Ding L, Zhang D, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19 [J]. Theranostics, 2018, 8(14): 3932-3948.
|
| [57] |
Garvey CM, Lau R, Sanchez A, et al. Anti-EGFR therapy induces EGF secretion by cancer-associated fibroblasts to confer colorectal cancer chemoresistance [J]. Cancers (Basel), 2020, 12(6): 1393.
|
| [58] |
Tang YA, Chen YF, Bao Y, et al. Hypoxic tumor microenvironment activates GLI2 via HIF-1alpha and TGF-beta2 to promote chemoresistance in colorectal cancer [J]. Proc Natl Acad Sci USA, 2018, 115(26): E5990-E5999.
|
| [59] |
Izumi D, Toden S, Ureta E, et al. TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer [J]. Cell Death Dis, 2019, 10(4): 267.
|
| [60] |
Ostermann E, Garin-Chesa P, Heider KH, et al. Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts [J]. Clin Cancer Res, 2008, 14(14): 4584-4592.
|
| [61] |
Wu F, Yang J, Liu J, et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer [J]. Signal Transduct Target Ther, 2021, 6(1): 218.
|
| [62] |
Guillen Diaz-Maroto N, Sanz-Pamplona R, Berdiel-Acer M, et al. Noncanonical TGFbeta pathway relieves the blockade of IL1beta/TGFbeta-Mediated crosstalk between tumor and stroma: TGFBR1 and TAK1 inhibition in colorectal cancer [J]. Clin Cancer Res, 2019, 25(14): 4466-4479.
|
| [63] |
Diaz-Maroto NG, Garcia-Vicien G, Polcaro G, et al. The blockade of tumoral IL1beta-mediated signaling in normal colonic fibroblasts sensitizes tumor cells to chemotherapy and prevents inflammatory CAF activation [J]. Int J Mol Sci, 2021, 22(9): 4960.
|
| [64] |
Khare T, Bissonnette M, Khare S. CXCL12-CXCR4/CXCR7 axis in colorectal cancer: therapeutic target in preclinical and clinical studies [J]. Int J Mol Sci, 2021, 22(14): 7371.
|
| [65] |
Wen D, Wang Y, Zhu Z, et al. Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer [J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(12): 165923.
|
| [66] |
Ferrer-Mayorga G, Gómez-López G, Barbáchano A, et al. Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer [J]. Gut, 2017, 66(8): 1449-1462.
|
| [67] |
Hanley CJ, Mellone M, Ford K, et al. Targeting the myofibroblastic cancer-associated fibroblast phenotype through inhibition of NOX4 [J]. J Natl Cancer Inst, 2018, 110(1): 109-120.
|